TNF and tuberculosis: Interestingly, a review of the therapeutic agents for Crohn’s inflammation suggested that previously prescribed anti-inflammatory agents were actually treating MAP [106,107,108], while the strong contemporary anti-inflammatory TNF inhibitors are permissive for both MAP and tuberculosis [109,110,111].